European Pharmaceutical Review
APRIL 25, 2024
Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. has predicted that the sector will value $18.85 billion by 2031. Catalent Inc.
European Pharmaceutical Review
MARCH 14, 2023
This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
AUGUST 29, 2023
The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for medicine) Mankind Pharma has introduced 120 DMF (Drug Master File) Quality Medicines in the Indian market. This initiative aims to ensure universal access to medicines of international calibre.
STAT
OCTOBER 10, 2023
The big blow to Sunovion, he said, was the loss of patent protection for Latuda, its best-selling schizophrenia drug, which led to competition from cheaper generic medicines. “The severance package that I received from Sunovion was very generous and will tide me over until December,” he said. Absolutely.”
PharmaState Academy
JANUARY 29, 2024
Discussions also covered the hierarchy in international marketing, expected packages, responsibilities, and territories of medical representatives and country managers. He highlighted potential opportunities due to the low cost of skilled labor, expanding market size, and increasing global demand for generic drugs.
Quality Matters
APRIL 18, 2024
For separate external shipping containers, USP has also reduced the need for plastic wrap and is evaluating smaller container sizes and biodegradable packaging materials, as well as a more easily recyclable alternative to EPS for cold-chain applications. In addition, they are more compact and 44% lighter than previous versions, on average.
pharmaphorum
MAY 27, 2022
Liam Johnstone has six years of toxicology experience working across regulators in the UK, developing expertise in medicine, consumer product and agrochemical safety whilst working at the MHRA, OPSS and HSE, respectively. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
Expert insights. Personalized for you.
84 
Let's personalize your content